PDK1/Akt/PDE4D axis identified as a target for asthma remedy synergistic with β2AR agonists by a natural agent arctigenin

Publisher： John Wiley & Sons Inc

E-ISSN： 1398-9995|70|12|1622-1632

ISSN： 0105-4538

Source： ALLERGY, Vol.70, Iss.12, 2015-12, pp. : 1622-1632

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Effects of Desloratadine versus Montelukast on Asthma Symptoms and Use of β2-Agonists in Patients with Seasonal Allergic Rhinitis and Asthma

By  

International Archives of Allergy and Immunology, Vol. 130, Iss. 4, 2003-05 ,pp. : 307-313

Karger

Access to resources Recommend Favorite

The CD1d-Natural Killer T Cell Axis in Atherosclerosis

By  

Journal of Innate Immunity, Vol. 6, Iss. 1, 2013-06 ,pp. : 3-12

Karger

Access to resources Recommend Favorite

Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting β2-agonists: addition of montelukast in an open-label pilot study

By Dupont Lieven   Potvin Emmanuel   Korn Dana   Lachman Albert   Dramaix Michèle   Gusman Julie   Peché Rudi  

Current Medical Research and Opinion, Vol. 21, Iss. 6, 2005-06 ,pp. : 863-870

Informa Healthcare

Access to resources Recommend Favorite

Inhalation devices for long-acting β2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD

By Molimard Mathieu   Till Denise   Stenglein Stephan   Singh Dilraj   Krummen Markus  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2405-2413

Informa Healthcare

Access to resources Recommend Favorite

SEMA3F prevents metastasis of colorectal cancer by PI3K–AKT‐dependent down‐regulation of the ASCL2–CXCR4 axis

By  

THE JOURNAL OF PATHOLOGY, Vol. 236, Iss. 4, 2015-08 ,pp. : 467-478

John Wiley & Sons Inc

Access to resources Recommend Favorite